These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27377321)

  • 1. Tau pathology in Creutzfeldt-Jakob disease revisited.
    Kovacs GG; Rahimi J; Ströbel T; Lutz MI; Regelsberger G; Streichenberger N; Perret-Liaudet A; Höftberger R; Liberski PP; Budka H; Sikorska B
    Brain Pathol; 2017 May; 27(3):332-344. PubMed ID: 27377321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.
    Rossi M; Kai H; Baiardi S; Bartoletti-Stella A; Carlà B; Zenesini C; Capellari S; Kitamoto T; Parchi P
    Acta Neuropathol Commun; 2019 Apr; 7(1):53. PubMed ID: 30961668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PART and ARTAG tauopathies at a relatively young age as a concomitant finding in sporadic Creutzfeldt-Jakob disease.
    Menšíková K; Matěj R; Parobková E; Smětáková M; Kaňovský P
    Prion; 2021 Dec; 15(1):138-142. PubMed ID: 34224311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain.
    Kovacs GG; Xie SX; Robinson JL; Lee EB; Smith DH; Schuck T; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2018 Jun; 6(1):50. PubMed ID: 29891013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.
    Kovacs GG; Ferrer I; Grinberg LT; Alafuzoff I; Attems J; Budka H; Cairns NJ; Crary JF; Duyckaerts C; Ghetti B; Halliday GM; Ironside JW; Love S; Mackenzie IR; Munoz DG; Murray ME; Nelson PT; Takahashi H; Trojanowski JQ; Ansorge O; Arzberger T; Baborie A; Beach TG; Bieniek KF; Bigio EH; Bodi I; Dugger BN; Feany M; Gelpi E; Gentleman SM; Giaccone G; Hatanpaa KJ; Heale R; Hof PR; Hofer M; Hortobágyi T; Jellinger K; Jicha GA; Ince P; Kofler J; Kövari E; Kril JJ; Mann DM; Matej R; McKee AC; McLean C; Milenkovic I; Montine TJ; Murayama S; Lee EB; Rahimi J; Rodriguez RD; Rozemüller A; Schneider JA; Schultz C; Seeley W; Seilhean D; Smith C; Tagliavini F; Takao M; Thal DR; Toledo JB; Tolnay M; Troncoso JC; Vinters HV; Weis S; Wharton SB; White CL; Wisniewski T; Woulfe JM; Yamada M; Dickson DW
    Acta Neuropathol; 2016 Jan; 131(1):87-102. PubMed ID: 26659578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes.
    Ferrer I; García MA; González IL; Lucena DD; Villalonga AR; Tech MC; Llorens F; Garcia-Esparcia P; Martinez-Maldonado A; Mendez MF; Escribano BT; Bech-Serra JJ; Sabido E; de la Torre Gómez C; Del Rio JA
    Brain Pathol; 2018 Nov; 28(6):965-985. PubMed ID: 29396893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical studies of the PrP(CJD) deposition in Creutzfeldt-Jakob disease.
    Tanaka S; Saito M; Morimatsu M; Ohama E
    Neuropathology; 2000 Jun; 20(2):124-33. PubMed ID: 10935449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic Tau Deposition Is Frequent in Typical and Atypical Alzheimer Disease Presentations.
    Nolan A; De Paula Franca Resende E; Petersen C; Neylan K; Spina S; Huang E; Seeley W; Miller Z; Grinberg LT
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1112-1123. PubMed ID: 31626288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies.
    Fraser E; McDonagh AM; Head M; Bishop M; Ironside JW; Mann DM
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):482-95. PubMed ID: 14507340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
    Ferrer I
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response.
    Kovacs GG; Yousef A; Kaindl S; Lee VM; Trojanowski JQ
    Neuropathol Appl Neurobiol; 2018 Aug; 44(5):491-505. PubMed ID: 28755467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
    Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
    Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Heidenhain variant of Creutzfeldt-Jakob disease and concomitant tau pathology: A case report.
    Ehler E; Pipka M; Meleková A; Mandysová P; Johanidesová S; Matěj R; Rusina R
    Neurol Neurochir Pol; 2017; 51(2):197-200. PubMed ID: 28236445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study.
    Iida MA; Farrell K; Walker JM; Richardson TE; Marx GA; Bryce CH; Purohit D; Ayalon G; Beach TG; Bigio EH; Cortes EP; Gearing M; Haroutunian V; McMillan CT; Lee EB; Dickson DW; McKee AC; Stein TD; Trojanowski JQ; Woltjer RL; Kovacs GG; Kofler JK; Kaye J; White CL; Crary JF
    Acta Neuropathol Commun; 2021 Aug; 9(1):134. PubMed ID: 34353357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of tau astrogliopathy in frontotemporal dementia caused by a novel Grn nonsense (Trp2*) mutation.
    Gómez-Tortosa E; Baradaran-Heravi Y; González Alvarez V; Sainz MJ; Prieto-Jurczynska C; Guerrero-López R; Agüero Rabes P; Van Broeckhoven C; van der Zee J; Rábano Gutiérrez A;
    Neurobiol Aging; 2019 Apr; 76():214.e11-214.e15. PubMed ID: 30545478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.
    Kovacs GG; Robinson JL; Xie SX; Lee EB; Grossman M; Wolk DA; Irwin DJ; Weintraub D; Kim CF; Schuck T; Yousef A; Wagner ST; Suh E; Van Deerlin VM; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 2017 Apr; 76(4):270-288. PubMed ID: 28340083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.